MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Bankruptcy Filing, Financial Collapse
ContraFect Corporation (NASDAQ: CFRX)
Organization & Developments: ContraFect
Parents
ContraFect Corporation (NASDAQ: CFRX)
Children
2017: ContraFect: Why Hasn't Anyone Else Done This Already? - CONTRAFECT Corp (NASDAQ:CFRX)
2018: ContraFect: Interesting Technology, Upcoming Catalyst, Cautious Outlook_seekingalpha.com
2020: ContraFect Corporation Is A Differentiated Infectious Disease Pick For 2020_seekingalpha.com
2022: ContraFect halts phase 3 after antimicrobial fails futility test against MRSA
Clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs) to treat gram-negative infections.
Jumps
Finance & Acquisitions: ContraFect
Key People: Contrafect